| Name: | Candesartan Cilexetil EP Impurity F |
| Catalogue No. | VL290004 |
| CAS No. | 914613-36-8 |
| Molecular Formula | C35H38N6O6 |
| Molecular Weight | 638.71 |
| Status | In-Stock |
| IUPAC Name | 2-Ethoxy-1-[[2'-(2-ethyl-2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester |
| Synonyms | Candesartan Cilexetil N2-Ethyl Impurity ; Candesartan Cilexetil Related Compound F |
| Description | Candesartan Cilexetil EP Impurity F (CAS No: 914613-36-8) Or 2-Ethoxy-1-[[2'-(2-ethyl-2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester, it is an impurity of Candesartan Cilexetil, Candesartan cilexetil is an ester prodrug that is hydrolysed to the active form candesartan,which is used to treat hypertension. |
| References | Sci-Hub | Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme | 10.1016/s0140-6736(03)14282-1. (2022). Retrieved January 1, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1016/s0140-6736(03)14282-1 |
